Fareva Drug For Further Processing
NDC Database

Fareva Drug For Further Processing

NDC Database

National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.

Drug for Further Processing
  • Total Records 6
  • Latest Marketing Date 2021-06-01
  • Data Source FDA
  • First Marketing Date 1998-08-12
All
23
View
Bulk Ingredient
17
View
Drug for Further Processing
6
View
Company Overview

Company

Fareva Drug For Further Processing

Country

Luxembourg

Website

Visit Website

Email

CMiksch.excella@fareva.com

Social Profiles

LinkedIn
Company Snapshot

Fareva Drug For Further Processing

28 place de la gare, 1616 Luxembourg

Luxembourg

www.fareva.com/en CMiksch.excella@fareva.com View on Map
NDC Records ( 6 records )
2020
01 Dec
Drug for Further Processing NDC: 78848-002

Nonproprietary Name

TEMSIROLIMUS

Dosage Form

INJECTION

Strength

25 mg/mL

Labeler

Fareva

Marketing Category

DRUG FOR FURTHER PROCESSING

78848-002

Substance

TEMSIROLIMUS

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2020-12-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2011
25 Aug
Drug for Further Processing NDC: 78848-003

Nonproprietary Name

BRENTUXIMAB VEDOTIN

Dosage Form

INJECTION

Strength

50 mg/10.5mL

Labeler

Fareva

Marketing Category

DRUG FOR FURTHER PROCESSING

78848-003

Substance

BRENTUXIMAB VEDOTIN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2011-08-25

End Marketing Date

-

Listing Record Certified Through

2027-12-31

1998
12 Aug
Drug for Further Processing NDC: 78848-004

Nonproprietary Name

MYCOPHENOLATE MOFETIL

Dosage Form

INJECTION

Strength

500 mg/5mL

Labeler

Fareva

Marketing Category

DRUG FOR FURTHER PROCESSING

78848-004

Substance

MYCOPHENOLATE MOFETIL

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

1998-08-12

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2000
08 Nov
Drug for Further Processing NDC: 78848-005

Nonproprietary Name

CETRORELIX

Dosage Form

INJECTION

Strength

0.25 mg/mL

Labeler

Fareva

Marketing Category

DRUG FOR FURTHER PROCESSING

78848-005

Substance

CETRORELIX

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2000-11-08

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2021
01 Jun
Drug for Further Processing NDC: 78848-006

Nonproprietary Name

TRASTUZUMAB

Dosage Form

INJECTION

Strength

150 mg/6.36mL

Labeler

Fareva

Marketing Category

DRUG FOR FURTHER PROCESSING

78848-006

Substance

TRASTUZUMAB

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2021-06-01

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2020
15 Apr
Drug for Further Processing NDC: 78848-007

Nonproprietary Name

TRASTUZUMAB

Dosage Form

INJECTION

Strength

420 mg/17.6mL

Labeler

Fareva

Marketing Category

DRUG FOR FURTHER PROCESSING

78848-007

Substance

TRASTUZUMAB

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2020-04-15

End Marketing Date

-

Listing Record Certified Through

2027-12-31

Related Databases
  • FDA Inspections
    5 View
  • EDQM CEP
    37 View
  • KDMF
    0 View
  • Japan DMF
    5 View
  • Eudra GMP
    0 View
  • NDC Database
    23 View
  • FDA Approved Drugs Database
    0 View
  • Drug Prices in Switzerland
    0 View
NDC Type Breakdown
6 total
  • Drug for Further Processing
Official Source

NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).

Visit FDA NDC Directory
NDC Record Details Preview

Explore important National Drug Code information available in the records above.

NDC

78848-002

Nonproprietary Name

TEMSIROLIMUS

Labeler

Fareva

Dosage Form

INJECTION

FDA NDC Data

National Drug Code information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized NDC records

NDC data is based on publicly available U.S. Food and Drug Administration (FDA) National Drug Code information.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit